From commercial payers to physician organizations, six physician leaders joined Becker's to discuss the healthcare power players they are watching.
Patsy Newitt
Physician autonomy has become a core concern as the workforce faces growing consolidation, with large healthcare systems, corporate entities and insurance companies increasingly influencing clinical decision-making and operational practices.
The U.S. House Sept. 23 has unanimously passed a bill allowing mail delivery of prescription drugs to Medicare patients.
The FDA on July 29 approved a screening test for colorectal cancer that requires only a blood sample.
A recent study by Avalere, funded by the American Independent Medical Practice Association, laid out how practice affiliation affects the share of gastroenterologists' Medicare beneficiaries.
Commercial and government payers alike are increasingly pushing patients to ASCs because of the cost-savings they can offer.
The proportion of Medicare-billing independent gastroenterologists declined from 31% to 13% between 2019 and 2022, according to a recent study by Avalere that was funded by the American Independent Medical Practice Association.
Brentwood, Tenn.-based ASC operator Surgery Partners could be the next "hot takeover" of the market, MarketBeat reported Sept. 25.
Santa Clara (Calif.) County's board of supervisors has unanimously approved the appropriation of $315 million to purchase a hospital from HCA Healthcare, one of the country's largest ASC operators.
Physicians could lose at least $25 billion in add-on payments for Part B drugs that could be part of the Inflation Reduction Act's program to negotiate drugs, according to a recent study by Avalere.
